Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

Federal Register Notices > Notices of Application - 2005 > Mallinckrodt Inc.

Notices of Application - 2005


FR Doc 05-6589 [Federal Register: April 4, 2005 (Volume 70, Number 63)] [Notices] [Page 17124-17125] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr04ap05-134]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to section 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on January 4, 2005, Mallinckrodt Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II:

Drug  Schedule 
Tetrahydrocannabinols (7370)   I
Codeine-N-oxide (9053)   I
Dihydromorphine (9145)   I
Difenoxin (9168)   I
Heroin (9200)   I
Morphine-N-oxide (9307)   I
Nicomorphine (9312)   I
Normorphine (9313)   I
Norlevorphanol (9634)   I
Amphetamine (1100)   II
Methamphetamine (1105)   II
Methylophenidate (1724)   II
Codeine (9050)   II
Diprenorphine (9058)   II
Etorphine HCL (9059)   II
Dihydrocodeine (9120)   II
Hydromorphone (9150)   II
Oxycodone (9143)   II
Diphenoxylate (9170)   II
Benzoylecgonine (9180)   II
Hydrocodone (9193)   II
Levorphanol (9220)   II
Meperidine (9230)   II
Methadone (9250)   II
Methadone Intermediate (9254)   II
Metopon (9260)   II
Dextropropoxyphene (9273)   II
Morphine (9300)   II
Thebaine (9333)   II
Opium extracts (9610)   II
Opium fluid extract (9620)   II
Opium tincture (9630)   II
Opium, powdered (9639)   II
Opium, granulated (9640)   II
Levo-alphacetylmethadol (9648)   II
Oxymorphone (9652)   II
Alfentanil (9737)   II
Remifentanil (9739)   II
Sufentanil (9740)   II
Fentanyl (9801)   II

The company plans to manufacture the listed controlled substances for internal use and for distribution to its customers.

Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to

[[Page 17125]]

DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson Davis Highway, Alexandria, Virginia 22301; and must be filed no later than June 3, 2005.

Dated: March 25, 2005.

William J. Walker, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 05-6589 Filed 4-1-05; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).

 


Registration Support  
Toll Free Number: 1-800-882-9539

ARCOS
| Career Opportunities | Chemical Program | Controlled Substance Schedules | Drugs and Chemicals of Concern  
Electronic Commerce Initiatives |  | Federal Register Notices | Import Export | Links | Meetings and Events | NFLIS
Offices & Directories | On-Line Forms & Applications | Program DescriptionPublications | Questions & Answers | Quotas  
  Reports Required by 21 CFR | Title 21 Regulations & Codified CSA
   Contact Us | HomeHot Items | Site Map | Search | What's New